title: [Identification and clinical use of the Metabolic Syndrome].
abstract: The Metabolic Syndrome is characterised by the following components: atherogenic dyslipidemia, elevated blood pressure, elevated glucose and abdominal obesity. 22% of 415 patients of an outpatient clinic in internal medicine fulfilled the criteria of a Metabolic Syndrome. The most common components were abdominal obesity, elevated blood pressure and elevated triglyceride. Only one in five treating physicians diagnosed a Metabolic Syndrome. Our data show that the concept of the Metabolic Syndrome has limited utility in clinical practice.
authors.affiliation: Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich, Rämistrasse 100, 8091 Zürich, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Baumgartner
authors.forename: S
authors.initials: S
authors.lastname: Gschwend
authors.forename: R
authors.initials: R
authors.lastname: Stöckli
authors.forename: E
authors.initials: E
authors.lastname: Battegay
authors.forename: L
authors.initials: L
authors.lastname: Zimmerli
mesh_terms: D000328:Adult; D001794:Blood Pressure; D008076:Cholesterol, HDL / Q000097:blood; D003430:Cross-Sectional Studies; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D008875:Middle Aged; D056128:Obesity, Abdominal / Q000150:complications / Q000175:diagnosis; D011446:Prospective Studies; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood
chemical_list: D008076:Cholesterol, HDL; D014280:Triglycerides